Effect of monocrotophos, an organophosphorus insecticide, on the striatal dopaminergic system in a mouse model of Parkinson’s disease.

Shaheen, Jafri Ali and Rajini, P. S. (2016) Effect of monocrotophos, an organophosphorus insecticide, on the striatal dopaminergic system in a mouse model of Parkinson’s disease. Toxicology and Industrial Health. pp. 1-13.

[thumbnail of Toxicology and Industrial Health 2016 1-13.pdf] PDF
Toxicology and Industrial Health 2016 1-13.pdf - Published Version
Restricted to Registered users only

Download (882kB)

Abstract

Our earlier study had shown that low concentrations of monocrotophos (MCP) elicited dopaminergic features
of Parkinson’s disease (PD) in the nematode Caenorhabditis elegans. In the present study, the effect of low doses
of MCP on the striatal dopaminergic neurons was investigated using the mouse model system. MCP was initially
screened for its ability to cause any neurobehavioral deficits and alterations in the dopaminergic system in
Swiss albino mice, aged 8 weeks and weighing 25–30 g, with repeated doses at 0.3 and 0.6 mg/kg body weight
(b.w.)/day for 7 days and 30 days. Mice were treated with four intraperitoneal injections for every 2 h with 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at the dosage of 14 mg/kg b.w. MCP was administered to
these mice at the above-mentioned doses for 7 days. Mice administered with MCP alone revealed a significant
(p < 0.05) reduction in the dopamine (DA) content at both 7 and 30 days and showed a significant (p < 0.05)
increase in neurobehavioral deficits. Interestingly, when MCP was administered for 7 days to MPTP-treated
mice, further significant decrease in both DA content and increase in neurobehavioral deficits were apparent.
The extent of reactive oxygen species and lipid peroxidation were markedly increased, while the ratio of
reduced to oxidized glutathione levels were significantly decreased (p < 0.05) in the treated mice as compared
to the control. Significant histopathological alterations and a marked reduction in the number of tyrosine
hydroxylase positive cells were evident in striatum of mice treated with higher doses of MCP. These changes
were comparable to that seen in mice treated with MPTP and post-administered lower doses of MCP. Our
findings suggest that MCP per se has the propensity to induce pathological changes in the dopaminergic neurons
as well as augment the degeneration in a compromised nigrostriatal system such as that in PD.

Item Type: Article
Uncontrolled Keywords: Dopamine, mice, monocrotophos, oxidative stress, Parkinson’s disease, striatum, tyrosine hydroxylase
Subjects: 500 Natural Sciences and Mathematics > 04 Chemistry and Allied Sciences > 26 Pesticide Chemistry
600 Technology > 01 Medical sciences > 09 Human Physiology
Depositing User: Food Sci. & Technol. Information Services
Date Deposited: 30 Jun 2017 09:29
Last Modified: 30 Jun 2017 09:29
URI: http://ir.cftri.res.in/id/eprint/12727

Actions (login required)

View Item
View Item